Trial Profile
Pilot Study of a Carbon 14 Oxaliplatin Microdosing Assay to Predict Exposure and Sensitivity to Oxaliplatin-Based Chemotherapy in Advanced Colorectal Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Mar 2021
Price :
$35
*
At a glance
- Drugs Oxaliplatin (Primary) ; Fluorouracil; Folinic acid
- Indications Adenocarcinoma; Colon cancer; Colorectal cancer; Rectal cancer
- Focus Adverse reactions
- 04 Mar 2021 Status changed from active, no longer recruiting to completed.
- 27 Aug 2020 Planned End Date changed from 1 Dec 2020 to 1 Jul 2021.
- 28 Jan 2020 Planned End Date changed from 1 Dec 2019 to 1 Dec 2020.